Sensei Biotherapeutics Inc Cash Flow-to-Debt Ratio
Sensei Biotherapeutics Inc cash flow-to-debt ratio. Sensei Biotherapeutics Inc (SNSE) has a Cash Flow-to-Debt Ratio of -0.76x as of March 2026, meaning its operating cash flow of $-10.73 Million could theoretically repay -1% of its total liabilities ($14.19 Million) in one year. See how financially flexible is Sensei Biotherapeutics Inc to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Sensei Biotherapeutics Inc (2018–2025)
Cash flow-to-debt ratio of Sensei Biotherapeutics Inc from 2018 to 2025. Historical debt coverage capacity for Sensei Biotherapeutics Inc across 8 annual periods. Also explore SNSE year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Sensei Biotherapeutics Inc Cash Flow-to-Debt Ratio by Year (2018–2025)
Sensei Biotherapeutics Inc cash flow-to-debt ratio by year from 2018 to 2025. Year-by-year debt coverage analysis for Sensei Biotherapeutics Inc. For the full cash flow conversion analysis, see Sensei Biotherapeutics Inc cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -4.75x | $-20.45 Million | $4.31 Million | ▼ -34.2% |
| 2024 | -3.54x | $-24.67 Million | $6.97 Million | ▼ -4.7% |
| 2023 | -3.38x | $-32.02 Million | $9.48 Million | ▼ -29.6% |
| 2022 | -2.61x | $-39.03 Million | $14.97 Million | ▲ +42.2% |
| 2021 | -4.51x | $-30.26 Million | $6.71 Million | ▼ -40.9% |
| 2020 | -3.20x | $-17.70 Million | $5.54 Million | ▼ -2507.9% |
| 2019 | -0.12x | $-8.57 Million | $69.88 Million | ▲ +34.2% |
| 2018 | -0.19x | $-10.31 Million | $55.33 Million | — |